Chronic obstructive pulmonary disease (COPD) is a lung disease characterised by chronic bronchitis, emphysema, and remodelling. Its prevalence is increasing worldwide, however there are few effective therapies, and none of the treatments currently available prevent the progression of the disease or target all of the hallmark features. The development and progression of COPD is heterogeneous, which has hampered the development of new therapies.

New drugs under development for COPD / Lo Bello, Federica; Hansbro, Philip M; Donovan, Chantal; Coppolino, Irene; Mumby, Sharon; Adcock, Ian M; Caramori, Gaetano. - In: EXPERT OPINION ON EMERGING DRUGS. - ISSN 1472-8214. - 25:4(2020), pp. 419-431. [10.1080/14728214.2020.1819982]

New drugs under development for COPD

Caramori, Gaetano
2020-01-01

Abstract

Chronic obstructive pulmonary disease (COPD) is a lung disease characterised by chronic bronchitis, emphysema, and remodelling. Its prevalence is increasing worldwide, however there are few effective therapies, and none of the treatments currently available prevent the progression of the disease or target all of the hallmark features. The development and progression of COPD is heterogeneous, which has hampered the development of new therapies.
2020
New drugs under development for COPD / Lo Bello, Federica; Hansbro, Philip M; Donovan, Chantal; Coppolino, Irene; Mumby, Sharon; Adcock, Ian M; Caramori, Gaetano. - In: EXPERT OPINION ON EMERGING DRUGS. - ISSN 1472-8214. - 25:4(2020), pp. 419-431. [10.1080/14728214.2020.1819982]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2964235
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact